Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro
- PMID: 1884095
- PMCID: PMC1908373
- DOI: 10.1111/j.1476-5381.1991.tb09789.x
Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro
Abstract
1. Platelet-activating factor (PAF, 10 nM) did not induce platelet adhesion to endothelial cells cultured in monolayer but it induced their adhesion to protein-coated plastic. However, PAF induced a marked platelet adhesion to endothelial cells when polymorphonuclear leukocytes (PMNs) were present. Lyso-PAF had no effect. 2. Phase-contrast microscopic examination showed that single platelets rather than their aggregates adhered to the endothelial cell surface around aggregating and adhering PMNs. 3. Significant platelet adhesion was induced by PAF at concentrations higher that 0.01 nM with the maximal response at 10 nM. Platelet adhesion occurred within minutes after PAF addition, reaching a maximum approximately after 30 min. Platelet adhesion also occurred significantly at a PMN:platelet ratio of 1:800, and linearly up to 1:50. 4. The PAF-induced platelet adhesion was suppressed by three structurally unrelated PAF antagonists, WEB 2086, ONO 6240 and BN 52021, in a concentration-dependent manner. 5. PAF also increased PMN adhesion to endothelial cell monolayers, which was further augmented by the presence of platelets. 6. The present study demonstrates that PAF induces platelet adhesion to endothelial cells in vitro when PMNs are present and that there is a close interaction between platelets and PMNs in their adhesion to endothelial cells. The present study further suggests that PMNs could play a central role in platelet adhesion to vascular endothlium in certain pathological conditions.
Similar articles
-
Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.Br J Pharmacol. 1996 Jan;117(2):299-304. doi: 10.1111/j.1476-5381.1996.tb15190.x. Br J Pharmacol. 1996. PMID: 8789382 Free PMC article.
-
PAF-mediated platelet adhesion to endothelial cells induced by FMLP-stimulated leukocytes.J Lipid Mediat. 1991 Nov;4(3):347-51. J Lipid Mediat. 1991. PMID: 1662550
-
Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.Br J Pharmacol. 1993 Jun;109(2):524-9. doi: 10.1111/j.1476-5381.1993.tb13601.x. Br J Pharmacol. 1993. PMID: 8358552 Free PMC article.
-
[Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].Vestn Akad Med Nauk SSSR. 1991;(10):13-7. Vestn Akad Med Nauk SSSR. 1991. PMID: 1801455 Review. Russian.
-
PAF antagonism as an approach to the treatment of airway hyperreactivity.Am Rev Respir Dis. 1991 Mar;143(3 Pt 2):S79-82. doi: 10.1164/ajrccm/143.3_Pt_2.S79. Am Rev Respir Dis. 1991. PMID: 2003696 Review.
Cited by
-
Nuclear localization of platelet-activating factor receptor controls retinal neovascularization.Cell Discov. 2016 Jul 12;2:16017. doi: 10.1038/celldisc.2016.17. eCollection 2016. Cell Discov. 2016. PMID: 27462464 Free PMC article.
-
Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.Br J Pharmacol. 1994 Mar;111(3):852-60. doi: 10.1111/j.1476-5381.1994.tb14816.x. Br J Pharmacol. 1994. PMID: 8019762 Free PMC article.
-
Dynamic blood cell contact with biomaterials: validation of a flow chamber system according to international standards.J Mater Sci Mater Med. 1997 Mar;8(3):119-29. doi: 10.1023/a:1018515001850. J Mater Sci Mater Med. 1997. PMID: 15348765
-
Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.Inflammation. 1996 Feb;20(1):57-70. doi: 10.1007/BF01487745. Inflammation. 1996. PMID: 8926049
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources